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from inhibitory control via spinal interneurones, thus facilitating 
the transmission of nociceptive information (Ahmadi et al., 2002; 
Reinold et al., 2005). One such mechanism of spinal disinhibition 
occurs through the postsynaptic activation of G-protein-coupled 
EP
2
 receptors, and subsequent protein kinase A induced inhibition 
of α3 subunit containing glycine receptors, present in the superfi cial 
laminae of the spinal cord (Harvey et al., 2004).
GlyR α3 subunit knockout mice (Glra3−/−) allow us to probe 
the function of this ligand-gated ion channel in the absence of any 
 subtype-selective ligands. Previously, a role for GlyR α3 in infl amma-
tory pain has been demonstrated in the CFA and zymosan A models 
of peripheral infl ammation (Harvey et al., 2004). By contrast, GlyR 
α3 appears to have little or no role in neuropathic pain and the 
formalin test (Racz et al., 2005; Hösl et al., 2006). In this study, we 
have investigated the nociceptive phenotypes of GlyR α3 knock-
out mice in acute models of infl ammation and clinically relevant 
models of persistent infl ammatory, neuropathic and visceral pain. 
Moreover, we investigated the role of GlyR α3 in response to multi-
modal suprathreshold stimuli-evoking responses, which equate to 
higher pain scores experienced by human pain patients.
MATERIALS AND METHODS
ANIMALS
Glra3−/− mice on a C57Bl/6 background were produced as described 
(Harvey et al., 2004). Glra3−/− mice and their wild-type littermates 
were group housed on a standard 12-h light/dark cycle with food 
and water available ad libitum except during behavioural testing. 
INTRODUCTION
Despite recent developments in the understanding of pain 
 mechanisms and analgesia, the relief of pain, particularly that which 
lasts over long periods, remains a principal concern to healthcare 
professionals. Chronic pain can be broadly categorised into three 
types: infl ammatory, neuropathic and dysfunctional. Infl ammatory 
pain, arising from tissue damage caused by trauma or infection, is 
 associated with conditions such as arthritis. Neuropathic pain, arising 
from trauma to, or pathological changes in, the peripheral or central 
nervous systems can occur as a consequence of stroke, ischaemia, 
diabetes or nerve infection (e.g. HIV, shingles, etc.). The third type 
of pain is underpinned by neural dysfunction and is thought to be 
associated with conditions such as irritable bowel syndrome (IBS), 
fi bromyalgia and migraine which manifest as non-localised diffuse 
pain unaccompanied by either infl ammation or nerve damage.
Tissue damage precipitates the release of multifarious endog-
enous pro-infl ammatory mediators at sites in both the periphery 
and the CNS (mainly at the level of the spinal cord). Peripheral 
release of these mediators, namely prostaglandin E
2
 (PGE
2
), leads to 
the sensitization of primary afferents, thereby lowering thresholds 
for neuronal activation, and increasing nociceptor responsivity. This 
increased peripheral activity contributes to spinal hypersensitivity 
(central sensitisation) resulting in increased responsivity to noxious 
stimulation termed hyperalgesia, and allodynia where normally non-
noxious stimuli such as cooling, gentle touch, movement and pres-
sure are now perceived as being painful. Central  prostanoid release 
can induce spinal disinhibition, relieving dorsal horn neurones 
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Experiments were performed on animals of at least 8 weeks of age. 
For all the experiments detailed in this study, the observer was 
blinded with respect to mouse genotype. All experiments were car-
ried out in accordance with the UK Home Offi ce Animals Scientifi c 
procedures Act (1986).
INDUCTION AND BEHAVIOURAL ANALYSIS OF PAIN STATES
Glra3−/− and wild-type littermates received either unilateral intra-
plantar injections of 1 mg/ml complete Freund’s adjuvant (CFA, 
20 µl), 2% (w/v) carrageenan (20 µl) or 50 µg/ml capsaicin (5 µl). 
Models of rheumatoid arthritis and osteoarthritis were induced 
by unilateral intra-articular injections of 3% (w/v) kaolin/carra-
geenan (K/C; 15 µl), or 5 mg/ml monosodium iodoacetate (MIA, 
10 µl; Harvey and Dickenson, 2009), respectively. Neuropathic 
(partial sciatic nerve ligation, PSNL) mice were prepared by uni-
lateral tight ligation of 1/3 to 1/2 of the sciatic nerve using 7-0 silk 
under isofl uorane/O
2
 anaesthesia (Malmberg and Basbaum, 1998). 
Behavioural thermal hypersensitivity (thermal hyperalgesia) was 
assessed using the Hargreaves’ test and the hot plate, and mechani-
cal hypersensitivity (mechanical allodynia) was assessed using von 
Frey fi laments as described (Harvey and Dickenson, 2009). Two 
baseline measurements were recorded prior to the induction of the 
pain models. Although both contralateral and ipsilateral limbs were 
tested, only ipsilateral data are shown for clarity since contralateral 
data were not signifi cantly different from baseline following the 
induction of any pain model (p > 0.05). Capsaicin-induced acute 
spontaneous pain behaviours, measured as either biting, fl inching, 
or licking, were measured for 3 min.
SPINAL CORD ELECTROPHYSIOLOGY
Following a laminectomy (L3–L6) in vivo electrophysiology was 
performed in urethane anesthetised (240 mg/kg) Glra3−/− and 
wild-type mice using parylene coated tungsten electrodes (A-M 
Systems, USA), as previously described (Harvey and Dickenson, 
2009). Evoked neuronal responses were recorded from single wide 
dynamic range dorsal horn neurones receiving inputs from the 
hindpaw. Transcutaneous electrical stimuli consisted of a train of 
16 electrical stimuli (2 ms wide pulses, 0.5 Hz, 3 × C fi bre thresh-
old), were delivered by means of pins inserted in to the hindpaw. 
Post stimulus time histograms were constructed and fi bre responses 
were separated according to the following latencies: A (0–50 ms), 
C (50–250 ms) and post discharge (250–800 ms). Input (i.e. 
non-potentiated response) is measured as the number of action 
potentials in response to the initial stimulus × 16 (total number of 
stimuli). Wind up values, a measure of the temporal summation 
of neuronal activity in response to a train of stimuli, was calcu-
lated as the total number of action potentials evoked at the end 
of 16 stimuli minus the input. A wide range of natural stimuli 
including brush (dynamic mechanical) acetone (innocuous cold), 
and graded punctate mechanical and thermal stimuli applied using 
von Frey fi laments and a water jet, respectively, were applied to the 
hindpaw for a period of 10 s. Data were captured and analysed using 
a CED 1401 interface coupled to a Pentium computer running Spike 
2 software (Cambridge Electronic Design).
ACUTE VISCERAL NOCICEPTION
Visceral nociception was assessed using a method adapted from 
Kamp et al. (2003). Under isofl uorane anaesthesia (2.5%, delivered 
in O
2
), an electromyographic (EMG) electrode (insulated copper 
wire, exposed at the ends and 1 cm centrally) was sewn into the 
external oblique muscle. A latex balloon (20 mm) attached to a 
pressure transducer via polyethylene tubing, with the distal 15 mm 
perforated using a 27-gauge needle to facilitate balloon infl ation, 
was inserted intra-anally (25 mm), and secured by surgical tape 
to the base of the tail. The anaesthesia was gradually reduced to 
∼1% isofl uorane, and allowed to equilibrate for at least 30 min, 
such that the animals did not display spontaneous movement but 
responded to cutaneous hindpaw stimulation. EMG responses were 
fi ltered, amplifi ed and recorded in 10 s prior to and during color-
ectal distensions (10 s) of 10–60 mmHg applied at 4 min intervals. 
Two consecutive sets of CRD were recorded and averaged. Data 
are presented relative to the mean wild type maximum response 
(60 mmHg).
RESULTS
ACUTE NOCICEPTION
Pain thresholds to punctate mechanical stimuli were measured in 
Glra3−/− mice and wild-type littermates using calibrated von Frey 
hairs, according to the up–down method (Chaplan et al., 1994). Paw 
withdrawal thresholds to mechanical stimuli were not signifi cantly 
different between groups (p > 0.05; Figure 1A). Similarly, thermal 
thresholds assessed using the Hargreaves’ test were  indistinguishable 
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FIGURE 1 | Glra3−/− mice show no differences in their acute pain 
behaviours. (A) Punctate mechanical stimulation using calibrated von Frey 
(Glra3−/−, n = 16; wild type, n = 10). Thermal stimulation using either (B) the 
Hargreaves’ apparatus (Glra3−/−, n = 30; wild type, n = 19) or (C) the hot plate at 
50°C or 55°C (Glra3−/−, n = 12; wild type, n = 12). Data are presented as 
mean ± SEM.
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between groups (p > 0.05; Figure 1B). Thermal hypersensitivities 
were similar across genotypes when measured using the hot plate 
at either 50°C or 55°C (p > 0.05; Figure 1C). This absence of an 
acute phenotype in Glra3−/− mice agrees with previous fi ndings 
(Harvey et al., 2004).
Spinal cord electrophysiology was performed to assess the poten-
tial role of GlyR α3 in acute nociception in response to multi-
modal stimuli. Where behaviour lends information concerning 
threshold intensities, electrophysiology can be used to inform us 
about responses to suprathreshold stimuli. Single unit dorsal horn 
neuronal recordings were performed in Glra3−/− (n = 27) and wild-
type littermates (n = 22). The mean depths from the surface of the 
spinal cord were not signifi cantly different between groups and 
correspond to the deep laminae of the spinal cord 550 ± 30 µm and 
459 ± 38 µm (p > 0.05), respectively ensuring that the population 
of neurons was similar between the two groups, and hence direct 
comparisons were possible. Responses to electrical, brush, acetone, 
noxious cold and pinch (Table 1); as well as graded mechanical 
and thermal stimuli (Figures 2A,B) were indistinguishable between 
genotypes (p > 0.05).
INFLAMMATORY PAIN BEHAVIOUR
Consistent with previously reported fi ndings (Harvey et al., 2004) 
Glra3−/− mice displayed showed no difference in the induction of 
thermal pain sensitisation following CFA (20 µl) injection, but 
recovered much more quickly compared with wild-type litter-
mate controls (Figure 3A). Paw withdrawal latencies to thermal 
stimulation using the Hargreaves’ apparatus were signifi cant versus 
contralateral responses for wild-type mice days 1–6 and days 1–3 
for Glra3−/− mice (p < 0.001). Consistent with previous fi ndings, 
Glra3−/− mice (n = 7) displayed signifi cant differences in thermal 
hypersensitivity at 4, 5 and 6 days following CFA injection com-
pared with wild-type littermates (n = 5, p < 0.01).
Acute cutaneous neurogenic infl ammation induced by intra-
dermal injection of capsaicin (5 µl; 50 µg/ml) elicited spontane-
ous pain behaviour in both Glra3−/− and wild-type control mice 
(Figure 3B). No signifi cant differences were observed between the 
type of nociceptive behaviour (i.e. licking, biting and fl inching) or 
the duration of such responses (p > 0.05).
Intraplantar injection of carrageenan (20 µl; 2% w/v) elicited 
signifi cant thermal and mechanical hypersensitivities in both 
Glra3−/− and wild-type control mice at both acute (2–6 h), and 
sub-acute phases (24 h) (p < 0.05–p < 0.001; Glra3−/−, n = 5; wild 
type, n = 7; Figures 3C,D). Statistical analysis revealed no sig-
nifi cant difference in Glra3−/− mice in either the magnitude or 
duration of thermal and mechanical hypersensitivities following 
carrageenan injection when compared with wild-type control lit-
termates (p > 0.05).
Clinically relevant models of infl ammation
Intra-articular injection of monosodium iodoacetate (MIA, 7 µl; 
5 mg/ml) to induce osteoarthritis (OA) evoked signifi cant behav-
ioural mechanical hypersensitivitiy in both Glra3−/− and wild-
type control mice when compared with contralateral controls 
(n = 6; p < 0.001; Figure 4A). Thermal hypersensitivity was not 
explored since this has been found to be absent in this model 
(Harvey and Dickenson, 2009). Similarly, a model of rheuma-
toid arthritis (kaolin/carrageenan; 15 µl, 3% w/v) evoked sig-
nifi cant thermal hypersensitivity in both Glra3−/− and wild-type 
control mice when compared with contralateral controls (n = 6; 
p < 0.05; Figure 4B). No signifi cant differences were observed 
between genotypes.
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FIGURE 2 | Glra3−/− mice show no differences in evoked dorsal horn neuronal responses. (A) Graded mechanical stimuli (von Frey); (B) graded thermal stimuli 
(water jet). Data are presented as mean ± SEM (Glra3−/−, n = 27; wild type, n = 22).
Table 1 | Glra3−/− mice show no alteration in their neuronal responses to 
multimodal stimuli. Data are presented as mean ± SEM for deep dorsal 
horn neurones recorded in Glra3−/− (n = 27) and wild-type mice (n = 22). AP 
represents the mean number of action potentials in response to either a 
peripheral electrical or 10-s natural stimulus.
 Glra3−/− Wild type
A-fi bre threshold (mA) 0.05 ± 0.08 0.07 ± 0.02
C-fi bre threshold (mA) 0.94 ± 0.18 0.92 ± 0.16
A-fi bre response (AP) 105 ± 10 85 ± 9
C-fi bre response (AP) 181 ± 19 143 ± 18
Post discharge (AP) 180 ± 25 155 ± 21
Input (AP) 216 ± 28 199 ± 29
Wind-up (AP) 186 ± 31 118 ± 20
Brush (AP) 67 ± 22 61 ± 14
Pinch (AP) 172 ± 29 154 ± 25
Acetone (AP) 14 ± 5 8 ± 5
1°C 60 ± 11 48 ± 20
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NEUROPATHIC PAIN BEHAVIOUR
Following the induction of peripheral nerve injury using the partial 
sciatic nerve ligation model, both Glra3−/− and wild-type littermates 
developed robust and persistent mechanical and thermal hyper-
sensitivities from the onset of testing (Figures 5A,B). Signifi cant 
mechanical hypersensitivity was observed in Glra3−/− mice at days 
3, 5, 7 and 14 (p < 0.01–p < 0.001) and wild-type mice at days 
3–14 (p < 0.05–p < 0.01) following surgery compared with con-
tralateral controls (n = 6). Signifi cant thermal hypersensitivity was 
observed in Glra3−/− mice and wild-type mice at all days following 
surgery (p < 0.001) compared with contralateral controls (n = 6). 
Statistical analysis revealed no signifi cant difference in Glra3−/− mice 
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FIGURE 4 | Glra3−/− mice show no differences in behavioural 
hypersensitivity in models of osteoarthritis or rheumatoid arthritis. 
(A) Signifi cant mechanical hypersensitivity was observed at all timepoints 
following unilateral intra-articular MIA (10 µl, 5 mg/ml) in both genotypes when 
compared with contralateral controls (n = 6; p < 0.001). (B) Signifi cant thermal 
hypersensitivity was observed at days 1 and 2 following unilateral intra-articular 
K/C injection (15 µl, 3% w/v) in both genotypes when compared with 
contralateral controls (n = 6; p < 0.05). No differences were observed between 
genotypes. Data are presented as mean ± SEM and analysed using two-way 
repeated measures ANOVA, Bonferroni post hoc analysis.
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FIGURE 3 | Glra3−/− mice display attenuated CFA behaviour, but show no 
differences in other infl ammatory models. (A) Paw withdrawal latencies 
following unilateral intraplantar CFA (20 µl) were signifi cant versus contralateral 
responses for wild-type mice days 1–6 and days 1–3 for Glra3−/− mice (p < 0.001). 
Paw withdrawal latencies of Glra3−/− mice were signifi cantly different from wild-
type mice at days 4 (p < 0.01, **), 5 and 6 (p < 0.001, ***) (Glra3−/−, n = 7; wild 
type, n = 5). (B) Total nociceptive behaviour following unilateral intraplantar 
capsaicin (5 µl, 50 µg/ml) was not signifi cantly different between genotypes 
(Glra3−/−, n = 12; wild type, n = 12). (C) Signifi cant mechanical hypersensitivity and 
(D) thermal hypersensitivity was observed at all timepoints following unilateral 
intraplantar carrageenan (20 µl, 2% w/v) when compared with contralateral 
controls (p < 0.05 –p < 0.001) but indistinguishable between genotypes (Glra3−/−, 
n = 5; wild type, n = 7). Data are presented as mean ± SEM and analysed using 
two-way repeated measures ANOVA, Bonferroni post hoc analysis.
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in either the magnitude or duration of thermal and mechanical 
 hypersensitivities following the induction of nerve injury when 
compared with wild-type control littermates (p > 0.05).
VISCERAL PAIN
The visceromotor response (VMR), evoked by the distension 
of the colon by a balloon inserted intra-colonically, provides 
a quantifi able measure of visceral pain (visceral hyperalgesia). 
In rodents, pressures which elicit pain in humans evoke graded 
abdominal muscle contractions (measured as the VMR), tachy-
cardia and the activation of primary afferent visceral nerves (e.g. 
pelvic nerve) and subsequent activation of second order pro-
jection neurones (Kamp et al., 2003). The response measured 
at 0 mmHg (with the balloon defl ated) was considered as the 
baseline response; 30 mmHg was considered mildly noxious and 
60 mmHg as signifi cantly noxious. Both wild-type and Glra3−/− 
mice displayed coded responses to the graded stimuli (Figure 6), 
however, the responses were not signifi cantly different between 
the groups (p > 0.05).
DISCUSSION
This study confi rms, consistent with previous fi ndings, that GlyR 
α3 has a signifi cant role in certain infl ammatory pain states. In this 
study, we have used knockout mice to investigate the role of GlyR 
α3 in a variety of acute, persistent and clinically relevant behav-
ioural pain models as well as neuropathic and visceral pain models. 
Moreover, in vivo electrophysiology has been used to investigate 
the potential role of these channels in response to suprathreshold 
stimuli, which equate to intensities that produce high pain scores 
such as those seen in the clinic.
ACUTE PAIN THRESHOLDS
Consistent with previous fi ndings, acute behavioural thermal and 
mechanical thresholds in Glra3−/− mice were unaltered (Harvey 
et al., 2004). These behavioural fi ndings are re-enforced by the 
electrophysiological characterisation of Glra3−/− mice to an array 
of different modalities ranging from threshold to suprathreshold 
intensities, suggesting that GlyR α3 is not implicated in acute 
 nociception. These characteristics are advantageous when inves-
tigating potential therapeutic targets since ideal analgesic targets 
should be pain-state specifi c, leaving normal nociceptive processing 
and thus normal sensation unaltered.
INFLAMMATORY PAIN MODELS
Although the role of GlyR α3 in infl ammatory pain has been pre-
viously investigated in selected models, this study expands on the 
current work by investigating its potential role in other infl amma-
tory pain states including capsaicin and carrageenan infl ammation 
and clinically relevant models such as the kaolin/carrageenan (K/C) 
model of rheumatoid arthritis and the monosodium iodoacetate 
model of osteoarthritis. CFA-induced behavioural hypersensitiv-
ity was reconfi rmed in this study, where Glra3−/− mice displayed 
an accelerated rate of recovery, in line with previous fi ndings 
(Harvey et al., 2004). Since GlyR α3 displayed this infl ammatory 
phenotype, its potential role in other models of infl ammation 
was investigated.
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FIGURE 6 | Glra3−/− mice show no differences in visceromotor responses 
to colorectal distension. Isofl urane anesthetised mice display graded 
visceromotor responses to increasing colorectal pressures. No differences 
were observed between genotypes (Glra3−/−, n = 5; wild type, n = 7). Data are 
presented as mean (normalised to maximum wild-type control) ± SEM.
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FIGURE 5 | Glra3−/− mice show no differences in behavioural 
hypersensitivitiy following experimentally induced peripheral neuropathy. 
(A) Signifi cant mechanical hypersensitivity was observed in Glra3−/− mice at days 
3, 5, 7 and 14 (p < 0.01–p < 0.001) and wild-type mice at days 3–14 (p < 0.05–
p < 0.01) following surgery compared with contralateral controls (n = 6). 
(B) Signifi cant thermal hypersensitivity was observed in Glra3−/− mice and wild-
type mice at all days following surgery (p < 0.001) compared with contralateral 
controls (n = 6). No differences were observed between genotypes. Data are 
presented as mean ± SEM and analysed using two-way repeated measures 
ANOVA, Bonferroni post hoc analysis.
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Intraplantar capsaicin elicits immediate spontaneous pain 
behaviour in rodents through the activation of the vanilloid recep-
tor 1 (VR1/TRPV1). This evoked nocifensive behaviour is thought 
to arise from the direct activation of C-fi bres rather than as a conse-
quence of local infl ammation per se. Although capsaicin-induced C 
fi bre activation has previously been found to elicit prostaglandin E
2
 
release in spinal cord slices (Malmberg and Yaksh, 1994), the exact 
spinal mechanisms have not been fully established. In this study, 
no behavioural phenotype was observed following intraplantar 
capsaicin injection in Glra3−/− mice.
Intraplantar injection of carrageenan evokes both mechanical 
and thermal hypersensitivity in rodents. These behaviours can 
be subdivided into an acute phase (2–6 h) and sub-acute phase 
(24 h) (Kolhekar et al., 1997). Prostaglandin synthesis occurs both 
at peripheral and spinal sites since both systemic and intrathecal 
cyclo-oxygenase (COX) inhibition attenuates nocifensive behav-
iour. However, intrathecal COX inhibitors were only effective when 
given prior to carrageenan injection (Dirig et al., 1998). A later 
study found that spinal CSF levels of PGE
2
 peaked in the acute 
phase but remained signifi cantly elevated up to 24 h (Guay et al., 
2004). Taken together, this suggests that there is potentially only a 
limited time frame where spinal PGE
2
 is contributing to the pain 
behaviours, whereas peripheral or supraspinal sites are involved 
in both the induction and maintenance of carrageenan-evoked pain 
behaviours. In this study, no phenotype was observed in either the 
acute or sub-acute phase of carrageenan behavioural hypersensitiv-
ity in Glra3−/− mice. Therefore, although spinal prostaglandins are 
involved in the induction, and to a lesser extent the maintenance 
of this model, the EP
2
 receptor – GlyR α3 signalling pathway is 
unlikely to represent the downstream substrate.
ARTHRITIC PAIN MODELS
Arthritic pain, as a result of either rheumatoid arthritis or osteoar-
thritis, represents a major chronic healthcare problem escalating 
with our aging and obese population (Neugebauer et al., 2007). 
Although different models exist for their study, the chemical mod-
els of MIA, for osteoarthritis, and K/C for rheumatoid arthritis, 
are popular among pain researchers. In this study, mice displayed 
signifi cant behavioural hypersensitivity in the paw of the affected 
limb in both arthritic models, consistent with other literature 
(Yang et al., 1996; Harvey and Dickenson, 2009). Similar to other 
peripheral infl ammatory models, spinal prostanoids are thought 
to contribute largely to the observed pain behaviours. Infrapatellar 
K/C injection leads to a robust and persistent (up to 72 h) increase 
in spinal PGE
2
 levels in rats (Dirig and Yaksh, 1999). In the MIA 
model of osteoarthritis, NSAIDs are only effective at the early stages 
of the model, suggesting a switch in the underlying mechanisms at 
later time points although these have not yet been fully established 
(Bove et al., 2003; Pomonis et al., 2005; Vonsy et al., 2008). In this 
study, it would appear that despite good evidence for central pros-
tanoid release, GlyR α3 is not implicated in the underlying pain 
pathophysiology.
NEUROPATHIC PAIN
The benefi ts of using NSAIDs to treat neuropathic pain remains 
controversial, and at best they may only be effective at very early 
stages following the nerve insult (Ma et al., 2002; Schafers et al., 
2004). In this study, analysis of the pain behaviours following 
the induction of peripheral nerve injury using the partial sciatic 
nerve injury model revealed that Glra3−/− mice developed profound 
mechanical and thermal hypersensitivities indistinguishable from 
wild-type littermates. This is in accordance with previous studies 
investigating the role of GlyR α3 in the chronic constriction injury 
model of neuropathic pain (Racz et al., 2005; Hösl et al., 2006). It 
is apparent, therefore, that unlike its clear role in certain types of 
infl ammatory pain, GlyR α3 is not critical for the induction or 
maintenance of neuropathic pain.
VISCERAL PAIN
Bowel disorders such as irritable bowel syndrome (IBS) are char-
acterised by poorly localised abdominal pain and sufferers dis-
play visceral hypersensitivity to experimental colorectal distension 
compared with healthy volunteers (Verne et al., 2001). To inves-
tigate the potential role of GlyR α3 in such bowel complaints we 
used a method of colorectal distension which produces a quan-
tifi able visceromotor response in lightly anaesthetised mice. In 
this study, although the magnitude of the VMR was dependent 
on the applied pressure, no signifi cant differences were observed 
between genotypes. This contrasts with other studies using the 
acetic acid writhing test, which reported a signifi cant attenuation 
in the writhing responses in Glra3−/− mice (Racz et al., 2005). This 
model, however, is often diffi cult to interpret as little is known 
about the pathophysiology following acetic acid injection. The 
acute testing regimen utilised in this study, however, may not be 
suffi ciently long to involve the proposed EP
2
 receptor – GlyR α3 
signalling pathway. A phenotype using the CRD model might be 
uncovered by future experiments involving colonic hypersensitiv-
ity where VMR are recorded in response to an irritant injected 
intra-colonically which enhance the VMR to both noxious and 
non-noxious intensities in rats (Coutinho et al., 1996), although 
care must be taken to avoid general systemic effects (Deitch et al., 
1992).
CONCLUSION
Since the contribution of a particular molecular substrate to the 
nociceptive phenotype will most likely depend on the origin of 
the pain (e.g. infl ammatory, neuropathic or dysfunctional), the 
temporal characteristics (i.e. acute or chronic), and the underlying 
sensitivity (peripheral or central) it is likely that different substrates 
underlie different pain states.
A selective role of GlyR α3 can be observed based on clear effects 
in the CFA model, yet there is no clear role in other infl ammatory, 
neuropathic or visceral pain models. This study, therefore, suggests 
that GlyR α3 may play an important role in mediating PGE
2
-
induced sensitisation, but only in certain pain states. Previously, 
GlyR α3 has been found not to contribute to behavioural hypersen-
sitivity following formalin injection (Hösl et al., 2006). Although 
this model, like most models of peripheral injury, evokes spinal 
PGE
2
 release and is attenuated by COX inhibitors, it most likely 
refl ects a different downstream target since EP2 receptor knock-
out mice, but not Glra3−/− mice, displayed attenuated nocifensive 
behaviour. This could also hold true for the other infl ammatory 
models investigated in this study and may point to the differential 
involvement of other prostanoids and EP receptors, located either 
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centrally or peripherally, that may activate different molecular 
effectors (e.g. Matsumoto et al., 2005; Hutchinson et al., 2009). 
What is clear, however, is that different infl ammatory pain states 
are underpinned by different molecular substrates such that their 
investigation will help to dissect out pain-state specifi c mecha-
nisms. These observations may be refl ected in different clinical 
phenotypes and, as such, a more mechanistic based approach may 
be required in the clinic.
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